Cutting G&A from 7.48M to 1.8M is no joke, that's real discipline. Now the question is whether they can scale without bloating costs again π
#BaddiesUSAChapterTHREE
$TTD $FLNC
@rosarioruiz1 Filing before headline is the right order every time. A signed forbearance beats guessing at the silence, now it's just about what the ventilation actually shows.
For the $CRWV crowd tracking infrastructure, $NXXT's Q2 2026 caught my eye: $27.75M revenue (+40.9%), $1.96M gross profit (+24.6%), and net loss down 81.7% to $6.62M. Fuel delivery drove the sales. Which metric matters most?
$NXXT $CRWV $QQQ #Energy
$end
$CRWV traders talk AI infrastructure, but I noticed $NXXT 's 2025 numbers: $81.8M revenue (+195%), $6.9M gross profit (+286%), margin up from 6.4% to 8.4%. Fuel delivery drove the expansion. What should the next report prove?
$NXXT $QQQ $CRWV #Energy#Growth
$NXXT flashed $1.61 (+763.27%) on a Nov 11, 10:58 AM ET Google Finance snapshot. After a -92.85% close on Nov 10, this is a violent intraday rebound, not a weekly gain. Watching the price and volumeβare you?
$NXXT $QQQ $RKLB #Stocks#trading
$VICP's Google Finance snapshot showed a $0.10β$1.50 52-week range and roughly 32.37M shares outstanding. A 15x range isn't a return anyone necessarily earned. For $RKLB traders, how much does OTC liquidity matter?
$VICP $QQQ $RKLB #Stocks
Paid in stock not cash, and 400 accounts plus a 50-state channel is real distribution. That's the kind of footprint that actually matters here.
#LNGSHOT_BANANAS
$QUBT $COIN
Ever wonder what $VICP paid for in its Sep 3 merger? Stateline's owners received Series C convertible shares, not cash. It added ~400 medical accounts and a 50-state channel. For $HIMS watchers, what makes a distributor valuable?
$VICP $QQQ $HIMS #Healthcare
Ever wonder what $VICP paid for in its Sep 3 merger? Stateline's owners received Series C convertible shares, not cash. It added ~400 medical accounts and a 50-state channel. For $HIMS watchers, what makes a distributor valuable?
$VICP $QQQ $HIMS #Healthcare
Here's a number I rarely see in $VICP posts: volume fell from 5,100 shares on Nov 2 to 1,400 on Nov 4, while both sessions closed at $0.50. For $CAPR traders, is the liquidity story as important as the science?
$VICP $MU $CAPR #OTCStocks
I found $VICP flagged for high illiquidity and missing recent financial data on Simply Wall St. The Sep 2026 merger added a drug distributor with ~400 medical accounts. What audited numbers would convince the $ABCL crowd?
$VICP $NVDA $ABCL #Biotech
A small study made me stop scrolling: a 2025 CXCL12 paper tied to $VICP followed just 2 primates, with C-peptide detected for 13 weeks in the diabetic animal. It's not human efficacy. For $CAPR traders, what comes next?
$VICP $MU $CAPR #Biotech
@TeamSituJomblo Commitment shares tell you the lender's incentive is real, always worth tracking. Make-whole terms are the sneaky part, good call noting the date.
I keep coming back to the manufacturing angle with $VICP. They're exploring a 120,000 sq. ft. facility in Puerto Rico, with about 50,000 sq. ft. of cleanroom space and another 70,000 sq. ft. for warehousing and distribution
That's a substantial footprint if the acquisition happens. Combine that with their existing Stateline operation, and you can see why management is thinking beyond basic drug distribution